Cingulate logo

Cingulate

CING | NASDAQ
Chart Builder DCF Calculator
$3.75
-$0.55 (-12.79%)
At close: Nov 16, 2026, 4:00 PM ET
$3.71
-$0.04 (-1.07%)
After-hours: Nov 16, 2026, 7:53 PM ET
-12.79%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
39
+3.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #552/1021 (Top 54%)

Key Statistics

Market Data

Market Cap $54.53M
1D Range
3.65 4.12
52W Range
3.33 11.66

Valuation (TTM)

PE -0.89
PB 0.00
EV/EBITDA N/A

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $9.00
Loading financial charts...

Profile

Cingulate Inc. is a biopharmaceutical enterprise currently in its clinical development phase, dedicated to devising therapeutic options for attention-deficit/hyperactivity disorder (ADHD). Leading its...

Sector Healthcare
Industry Biotechnology
Employees 14
IPO Date Dec 8, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$9.00
Upside
+140.00%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.